Dr. Ahmed Sobhy Darwish | Decision-making and Problem-solving | Leadership and Research Excellence Award

Dr. Ahmed Sobhy Darwish | Decision-making and Problem-solving | Leadership and Research Excellence Award

Egyptian International Pharmaceutical Industries, EIPICO; Zagazig university | Egypt

Author Profile

Google Scholar 

Scopus

Early Academic Pursuits

Ahmed Sobhy Abdelrahim Abdallah Darwish embarked on his academic journey with a keen interest in the foundational sciences, choosing to specialize in Chemistry-Physics at Zagazig University. From the outset, his passion for the intricacies of analytical processes and his rigorous approach to problem-solving set him apart from his peers. This academic foundation served as a springboard for further specialization, as he pursued a diploma in analytical chemistry, followed by a pre-master qualification, both of which he completed with distinction. His continued thirst for knowledge led him to complete a master’s degree in analytical chemistry, laying a strong conceptual and technical groundwork for his future endeavors. Currently undertaking a Ph.D. in the same field, he remains deeply committed to scholarly advancement and scientific excellence.

Professional Endeavors

Parallel to his academic growth, Darwish cultivated a multifaceted professional career in the pharmaceutical industry, beginning as a chemist in a quality control (Q.C.) laboratory. His meticulous attention to detail and mastery of analytical techniques allowed him to rise rapidly through the ranks. He assumed positions of increasing responsibility, including section head roles in both stability and methodology departments across various pharmaceutical firms. Today, he holds the role of Labs Development Deputy Manager at the Egyptian International Pharmaceutical Industries Company (EIPICO), where he leads a team of ten staff members. In this capacity, he oversees critical operations such as method development, comparative in vitro bioequivalence studies, and stress stability research. His role demands not only technical leadership but also strategic planning, regulatory compliance, and a continuous drive toward innovation.

Contributions and Research Focus

Darwish’s research is rooted in his strong belief in sustainable and efficient analytical practices. His work consistently demonstrates a commitment to green chemistry principles and pharmaceutical relevance. Among his completed research projects are numerous validated HPLC methods that combine ecological sensibility with robust analytical precision. His research includes the development of stability-indicating methods for a range of pharmaceutical compounds, such as piracetam, vincamine, levomenol, netilmicin, colchicine, khellin, valsartan, and sacubitril. These studies not only support pharmaceutical quality assurance but also contribute to reducing the environmental footprint of analytical laboratories. By incorporating certified green reference materials and simple yet effective chromatographic techniques, Darwish has contributed to the emerging field of environmentally sustainable pharmaceutical analysis. His work on multi-analyte quantification using RP-HPLC exemplifies his ability to integrate sensitivity, selectivity, and ecological responsibility.

Accolades and Recognition

Throughout his career, Darwish has built a reputation as a dependable and technically skilled leader. He has successfully negotiated with major global and regional regulatory bodies, including the United States Pharmacopoeia (USP), European Pharmacopoeia (EP), British Pharmacopoeia (BP), and national drug authorities such as those in Saudi Arabia, Romania, and Jordan. These engagements highlight the high regard in which his expertise is held and reflect the global applicability of his scientific contributions. His ability to represent his institution in discussions with these respected bodies speaks to both his technical command and his communication acumen.

Impact and Influence

Darwish’s influence extends beyond the laboratory bench. In his current managerial role, he serves as both a mentor and a catalyst for innovation. By nurturing a team of researchers and guiding them through the complexities of pharmaceutical development, he has created an environment where scientific rigor meets collaborative spirit. His focus on comparative in vitro studies supports generic drug development, which plays a vital role in making healthcare more affordable and accessible. The techniques and protocols he develops are frequently adapted by colleagues, shaping laboratory practices and ensuring consistent product quality within the industry.

Legacy and Future Contributions

As a scholar-practitioner, Darwish exemplifies the synergy between academic inquiry and industrial application. His trajectory points to a future marked by ongoing contributions to analytical chemistry and pharmaceutical sciences, with a special emphasis on eco-conscious practices. He aims to continue bridging the gap between scientific innovation and regulatory standards, fostering methods that not only meet but exceed global compliance benchmarks. His leadership within EIPICO is expected to drive further innovations in laboratory development, including advanced stability studies and green method validation strategies. With an unwavering dedication to scientific excellence, Darwish is poised to leave a lasting legacy in the field of pharmaceutical analysis — one grounded in sustainability, precision, and impact-driven research.

Notable Publications

Environmental sustainability profiles assessment of HPLC stability indicating method for quantitation of piracetam and vincamine in pharmaceutical medications

Authors: SS Alenezi, AA Gouda, R El Sheikh, NA Badahdah, ME Alzuhiri, AS Darwish
Journal: Talanta Open
Year: 2025

An ecologically sound HPLC determination of LEVOMENOL in topical therapies using a certified reference material with green properties

Authors: JK Ma, AS Darwish, A Al Ali, AM Abdelazim, WS Darwish, X Li, XC Huang
Journal: Results in Chemistry
Year: 2025

A Simple Eco‐Friendly Stability‐Indicating HPLC Method for Determination of NETILMICIN in Bulk and Ophthalmic Solution

Authors: AS Darwish, MSA Zaki, AGKA Salih, MA Ellatif, AA Patel, AK Mallick, …
Journal: Biomedical Chromatography
Year: 2025

Developing a sensitive, ecological, and economic HPLC method for the concurrent quantification of KOLCHICINE and KHELLIN, used in bulk and sachet pharmaceuticals

Authors: WSD, Ahmed Sobhy Darwish, Mohamed Samir Ahmed Zaki, Ali GadKarim A. Salih, …
Journal: Microchemical Journal
Year: 2025

Simple validated approach to quantify valsartan and sacubitril in medications using liquid chromatography

Authors: AS Darwish, AA Gouda, AS Eldien
Journal: Bulletin of Faculty of Science, Zagazig University
Year: 2025

Mr. Yi Deng | Decision-making and Problem-solving | Best Researcher Award

Mr. Yi Deng | Decision-making and Problem-solving | Best Researcher Award

Mr. Yi Deng | Decision-making and Problem-solving | Best Researcher Award, China

Author Profile

ORCID

🎓 Early Academic Pursuits

Yi Deng’s academic journey reflects a consistent pursuit of excellence and a passion for finance, business, and sustainable development. Her foundational years were shaped at the University of International Business and Economics (UIBE), one of China’s most prestigious institutions for business and finance. There, she earned a Bachelor’s degree in Management, majoring in Information Management and Information Systems, which provided her with a solid grounding in data analysis, information systems, and decision-making tools—skills that would later become crucial in her research on ESG metrics and corporate finance.

Her interest in the complex dynamics of organizations and markets led her to pursue a Master’s degree in Business Administration at UIBE, where she deepened her understanding of business operations, financial markets, and strategic management. This blend of technical knowledge and business acumen set the stage for her entry into academic research at the highest level.

👩‍💼 Professional Endeavors

Yi Deng is currently a Ph.D. Candidate in Finance at the China School of Banking and Finance, UIBE. Her doctoral studies have enabled her to explore the intersection of environmental, social, and governance (ESG) issues and corporate finance, aligning her research with some of the most urgent and globally relevant challenges in the business world today.

She has shown a strong commitment to academic rigor and intellectual curiosity, which is evident from her selection of complex and high-impact research topics. Yi is particularly focused on how ESG considerations are reshaping traditional finance theories, such as capital structure, and is exploring how rating disagreements among ESG agencies influence a firm’s dynamic financial strategies.

🔬 Contributions and Research Focus

At the heart of Yi Deng’s research portfolio lies a deep engagement with sustainable investment, capital structure dynamics, and corporate governance. Her research titled “ESG Rating Disagreement and Dynamic Capital Structure Adjustment” delves into the inconsistencies in ESG ratings issued by different agencies and examines how these variations impact firms’ strategic financial decisions.

This work contributes significantly to both academic literature and practical policy discussions. It challenges traditional assumptions in finance by showing how sustainability metrics, when inconsistent, can distort market signals and affect capital allocation efficiency. Her paper has been published in the internationally recognized, peer-reviewed journal, the Pacific-Basin Finance Journal—a noteworthy achievement that underscores the quality and relevance of her research.

Yi Deng’s commitment to empirical precision, combined with a sharp focus on sustainability, positions her among the new generation of finance scholars contributing to the evolution of corporate financial theory in the era of ESG.

🏆 Accolades and Recognition

While still early in her academic career, Yi Deng’s publication in the Pacific-Basin Finance Journal serves as a significant milestone. The journal is known for its rigorous standards and international readership, indicating that her work has met global academic expectations in both methodology and originality.

Although she has not yet accumulated formal accolades, memberships, or editorial appointments, her current achievements as a doctoral candidate already suggest a trajectory marked by excellence and influence. The acceptance and recognition of her research by a top-tier journal speak volumes about her potential and the value of her scholarly contributions.

🌏 Impact and Influence

Yi Deng’s research resonates in academic, financial, and sustainability circles alike. At a time when ESG considerations are increasingly central to investor behavior, regulatory frameworks, and corporate strategy, her work offers valuable insights into the real-world consequences of ESG rating disagreements. It informs not only academics and students but also policymakers and practitioners navigating the evolving landscape of sustainable finance.

By highlighting the potential misalignments caused by conflicting ESG ratings, Yi is helping shape a more transparent, accountable, and effective system for evaluating corporate sustainability. Her findings also contribute to understanding how firms adjust their capital structures in response to external evaluations—a crucial insight for investors, financial managers, and regulators alike.

🌟 Legacy and Future Contributions

As a rising scholar in finance, Yi Deng is poised to leave a lasting imprint on the academic and practical understanding of ESG and corporate finance. Her early work lays a strong foundation for future research that could influence policy reform, investment strategy, and corporate behavior in the context of sustainability. With continued exploration and academic engagement, she is well-positioned to become a thought leader in the field of sustainable investment and ESG integration.

Looking forward, Yi aims to expand her research to include international comparisons of ESG frameworks, the behavioral implications of ESG-related disclosure practices, and the role of regulatory mechanisms in standardizing ESG assessments. Through interdisciplinary collaboration and global engagement, she aspires to contribute to a more informed, responsible, and sustainable global financial system.

📝Notable Publications

ESG Rating Disagreement and Dynamic Capital Structure Adjustment

Author(s): Yifan Yang, Yi Deng
Journal: Pacific-Basin Finance Journal
Year: 2025